Arqule Inc. buy melinda
Start price
04.05.17
/
50%
€0.90
Target price
10.05.17
€0.99
Performance (%)
-3.51%
End price
10.05.17
€0.87
Summary
This prediction ended on 10.05.17 with a price of €0.87. With a performance of -3.51%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arqule Inc. | - | - | - | - |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% | 113.046% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% | 68.687% |
Comments by melinda for this prediction
In the thread Arqule Inc. diskutieren
intrahepatischen cholangiocarcinoma
hat Einschreibung von Phase 2. Diskussion Post at ASCO am 3. abgeschlossen Juni 2017. Phase 3 für das 3. Quartal 2017 geplant.